Home / CACNB3 Knockout Cell Lines

CACNB3 Knockout Cell Lines

Gene: CACNB3

Official Full Name: calcium voltage-gated channel auxiliary subunit beta 3provided by HGNC

Gene Summary: This gene encodes a regulatory beta subunit of the voltage-dependent calcium channel. Beta subunits are composed of five domains, which contribute to the regulation of surface expression and gating of calcium channels and may also play a role in the regulation of transcription factors and calcium transport. [provided by RefSeq, Oct 2011]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO10902 CACNB3 Knockout cell line (HeLa) Human CACNB3 1:3~1:6 Negative Online Inquiry
KO10903 CACNB3 Knockout cell line (HCT 116) Human CACNB3 1:2~1:4 Negative Online Inquiry
KO10904 CACNB3 Knockout cell line (HEK293) Human CACNB3 1:3~1:6 Negative Online Inquiry

Background

CACNB3 Gene Knockout Cell Lines represent a specific suite of genetically modified cell lines where the CACNB3 gene has been functionally inactivated. This gene encodes the beta-3 subunit of voltage-gated calcium channels, playing a critical role in calcium ion homeostasis and signal transduction within cells. By utilizing advanced CRISPR-Cas9 technology, these knockout cell lines provide a powerful tool for elucidating the physiological implications of disrupted calcium signaling pathways and investigating the role of CACNB3 in various cellular processes, including neurotransmission, muscle contraction, and regulation of gene expression.

The primary function of these knockout cell lines lies in their ability to provide a model system for studying cellular responses to calcium signaling. By comparing the behavior of CACNB3-deficient cells to their wild-type counterparts, researchers can explore the downstream effects of altered calcium influx on cellular function, investigate possible compensatory mechanisms, and assess the impact on associated signaling pathways. This valuable insight can aid in advancing our understanding of diseases associated with calcium dysregulation, such as cardiac and neurological disorders.

In clinical and research settings, CACNB3 Gene Knockout Cell Lines are instrumental for drug discovery and development, particularly in screening new therapeutic agents targeting calcium channel interactions. They allow for the identification of potential candidates that can modulate the aberrant signaling associated with CACNB3, facilitating advances in personalized medicine and targeted therapies.

One significant advantage of our CACNB3 Gene Knockout Cell Lines is their robustness and reproducibility, offering consistent results that directly enhance experimental validity. Furthermore, these cell lines are well characterized and can be easily integrated into existing workflows, providing seamless compatibility with a variety of assays, including high-throughput screening and functional studies.

For researchers and clinicians seeking to innovate and explore novel therapeutic avenues, the CACNB3 Gene Knockout Cell Lines are invaluable resources that not only simplify complex experimental designs but also empower scientific discovery. At our company, we are committed to providing state-of-the-art biological products backed by extensive expertise in genetic engineering, ensuring that our offerings meet the highest standards of quality and scientific rigor.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.